Features - Clinical Trials Arena https://www.clinicaltrialsarena.com/features/ Hard data and deep insights on clinical trials strategy & operations Fri, 25 Oct 2024 11:22:15 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2022/01/cropped-Clinical-Trials-Arena-32x32.png Features - Clinical Trials Arena https://www.clinicaltrialsarena.com/features/ 32 32 Adapting diabetes clinical trials to embrace underrepresented communities https://www.clinicaltrialsarena.com/features/adapting-diabetes-clinical-trials-to-embrace-underrepresented-communities/ Fri, 25 Oct 2024 11:22:00 +0000 https://www.clinicaltrialsarena.com/uncategorized/adapting-diabetes-clinical-trials-to-embrace-underrepresented-communities/ Solutions are needed to bridge gaps in communication that can prevent underserved communities from entering diabetes clinical trials.

The post Adapting diabetes clinical trials to embrace underrepresented communities appeared first on Clinical Trials Arena.

]]> The post Adapting diabetes clinical trials to embrace underrepresented communities appeared first on Clinical Trials Arena.

]]> Mapping out strategies to overcome challenges in clinical research https://www.clinicaltrialsarena.com/features/mapping-out-strategies-to-overcome-challenges-in-clinical-research/ Tue, 22 Oct 2024 12:46:46 +0000 https://www.clinicaltrialsarena.com/features/mapping-out-strategies-to-overcome-challenges-in-clinical-research/

The post Mapping out strategies to overcome challenges in clinical research appeared first on Clinical Trials Arena.

]]>

The post Mapping out strategies to overcome challenges in clinical research appeared first on Clinical Trials Arena.

]]> BIOSECURE Act: Companies turn to US manufacturers https://www.clinicaltrialsarena.com/features/biosecure-companies-turning-united-states-manufacturing/ Tue, 15 Oct 2024 08:12:44 +0000 https://www.clinicaltrialsarena.com/features/biosecure-companies-turning-united-states-manufacturing/ During Covid-19, US companies had to find onshore manufacturing. Experts believe this may also be an answer to the BIOSECURE Act.

The post BIOSECURE Act: Companies turn to US manufacturers appeared first on Clinical Trials Arena.

]]> The post BIOSECURE Act: Companies turn to US manufacturers appeared first on Clinical Trials Arena.

]]> Obesity trial surge puts the focus back on decentralisation  https://www.clinicaltrialsarena.com/features/obesity-trial-surge-puts-the-focus-back-on-decentralisation/ Fri, 11 Oct 2024 13:32:30 +0000 https://www.clinicaltrialsarena.com/features/obesity-trial-surge-puts-the-focus-back-on-decentralisation/ As the obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a role.

The post Obesity trial surge puts the focus back on decentralisation  appeared first on Clinical Trials Arena.

]]> The post Obesity trial surge puts the focus back on decentralisation  appeared first on Clinical Trials Arena.

]]> Cassava Sciences: Phase III trials storm ahead amid controversy https://www.clinicaltrialsarena.com/features/cassava-sciences-next-steps-sec-filing/ Wed, 09 Oct 2024 10:51:03 +0000 https://www.clinicaltrialsarena.com/features/cassava-sciences-next-steps-sec-filing/ Speaking to the Clinical Trials Arena, experts share their thoughts on the next steps for Cassava Sciences.

The post Cassava Sciences: Phase III trials storm ahead amid controversy appeared first on Clinical Trials Arena.

]]> The post Cassava Sciences: Phase III trials storm ahead amid controversy appeared first on Clinical Trials Arena.

]]> Ushering in a new era of fit-for-purpose clinical endpoints for Rett syndrome https://www.clinicaltrialsarena.com/features/ushering-in-a-new-era-of-fit-for-purpose-clinical-endpoints-for-rett-syndrome/ Mon, 07 Oct 2024 07:00:00 +0000 Biosensors and biomarkers could provide valuable secondary data, but challenges remain with implementation and data collection.

The post Ushering in a new era of fit-for-purpose clinical endpoints for Rett syndrome appeared first on Clinical Trials Arena.

]]> The post Ushering in a new era of fit-for-purpose clinical endpoints for Rett syndrome appeared first on Clinical Trials Arena.

]]> Pipeline Moves: Pfizer scores in Phase II cancer cachexia trial https://www.clinicaltrialsarena.com/features/pipeline-moves-pfizer-scores-in-phase-ii-cancer-cachexia-trial/ Mon, 30 Sep 2024 09:00:00 +0000 This week on Pipeline Moves, the Clinical Trials Arena team investigates candidates in oncology, central nervous system and women’s health.

The post Pipeline Moves: Pfizer scores in Phase II cancer cachexia trial appeared first on Clinical Trials Arena.

]]> The post Pipeline Moves: Pfizer scores in Phase II cancer cachexia trial appeared first on Clinical Trials Arena.

]]> Mpox: Three ongoing vaccine trials to watch https://www.clinicaltrialsarena.com/features/trials-to-watch-mpox/ Thu, 19 Sep 2024 09:10:30 +0000 https://www.clinicaltrialsarena.com/features/trials-to-watch-mpox/ As the World Health Organization (WHO) has declared mpox an emergency, the Clinical Trials Arena team investigates ongoing vaccine trials.

The post Mpox: Three ongoing vaccine trials to watch appeared first on Clinical Trials Arena.

]]> The post Mpox: Three ongoing vaccine trials to watch appeared first on Clinical Trials Arena.

]]> Pipeline Moves: Novo Nordisk’s liraglutide scores in Phase III paediatric trial https://www.clinicaltrialsarena.com/features/novo-nordisk-saxenda-scores-paediatric-trial/ Mon, 16 Sep 2024 15:59:02 +0000 https://www.clinicaltrialsarena.com/features/novo-nordisk-saxenda-scores-paediatric-trial/ The Clinical Trials Arena team investigates assets in infectious diseases, metabolic disorders, oncology and ophthalmology.

The post Pipeline Moves: Novo Nordisk’s liraglutide scores in Phase III paediatric trial appeared first on Clinical Trials Arena.

]]> The post Pipeline Moves: Novo Nordisk’s liraglutide scores in Phase III paediatric trial appeared first on Clinical Trials Arena.

]]> Alzheimer’s heterogeneity necessitates diverse enrollment in clinical trials https://www.clinicaltrialsarena.com/features/alzheimers-heterogeneity-necessitates-diverse-enrollment-in-clinical-trials/ Thu, 12 Sep 2024 20:23:40 +0000 https://www.clinicaltrialsarena.com/features/alzheimers-heterogeneity-necessitates-diverse-enrollment-in-clinical-trials/ Clinical trials need to evolve screening criteria to include diverse patient groups as more Alzheimer's disease drugs become available.

The post Alzheimer’s heterogeneity necessitates diverse enrollment in clinical trials appeared first on Clinical Trials Arena.

]]> The post Alzheimer’s heterogeneity necessitates diverse enrollment in clinical trials appeared first on Clinical Trials Arena.

]]>